BillionToOne
BillionToOne Overview
BillionToOne: The Game Changer in Molecular Diagnostics
Prepare yourself for a journey into the world of molecular diagnostics with BillionToOne, a company that's as unique as its name. This high-growth company is one of the top 5% of Y Combinator companies and has received over $250M in funding, which is no small feat, folks!
BillionToOne is not just about numbers, it's about counting what matters the most - DNA molecules. They've developed a DNA molecular counter that enhances cfDNA diagnostic resolution by over 1,000 fold. Imagine that! They've turned the world of molecular diagnostics on its head and given it a good shake.
UNITY™: The First of Its Kind
BillionToOne is the proud parent of UNITY™, the first and only non-invasive prenatal test. This little gem can screen an unborn baby's risk for both common and severe recessive gene disorders and chromosomal abnormalities. And it does this from a single tube of blood from the pregnant mother. No need for paternal testing. Talk about a game changer!
Northstar: Guiding the Way in Oncology Treatment
Fast forward to 2023, and BillionToOne launched two liquid biopsy products that are set to revolutionize oncology treatment and care. With Northstar Select™, clinicians can choose cancer therapies based on a patient's individual genetic makeup. Northstar Response™ allows them to monitor a patient’s early response to these therapies, reducing ineffective treatments and improving clinical outcomes.
A Culture of Transparency and Innovation
At BillionToOne, they're not just about groundbreaking products. They're about creating a culture of transparency and innovation. This is a company where weekly Town Hall meetings are the norm, and where employees are encouraged to bring their best selves to work every day.
Benefits and Perks Galore
Working at BillionToOne means enjoying a host of benefits and perks. From 100% paid employee premiums on select health plans and generous Family Bonding Leave for new parents, to free daily on-site lunches and state-of-the-art gym facilities, BillionToOne knows how to take care of its team. And let's not forget about the free on-site EV charging. Yes, you read that right!
So there you have it. BillionToOne: a company that's making the world of molecular diagnostics more accessible, one DNA molecule at a time.
What are typical salaries at BillionToOne?
Are you considering a career at BillionToOne? Gain insight into the potential financial rewards with our comprehensive salary guide. Based on publicly available data, we've compiled the estimated salary ranges for various roles. This information aims to empower you in your job search and career planning with BillionToOne.
| Role / Job Title | Salary Range |
|---|---|
| Director/Sr. Director of Market Access, Policy Development, Oncology | 200k-350k USD |
| Sr. Clinical Genomics Scientist, Prenatal | 150k-170k USD |
| Manager/Sr. Manager, Brand Marketing | 130k-200k USD |
| Prenatal Account Manager, Iowa North (Cedar Rapids, Davenport, Debuque) | 115k-165k USD |
| Prenatal Account Manager, Montana (incl. Northern part of WY) | 115k-165k USD |
Remember, your compensation at BillionToOne may include factors beyond base salary. For example, review perks such as health benefits, vacation time, and equity to understand total compensation.
Does BillionToOne allow remote work or work from home?
Yes they do! Based on the fact that BillionToOne has listed a remote job, it's safe to say that they are open to remote work and are actively looking for talented individuals to join their team, regardless of their location.
About BillionToOne
Recent remote jobs at BillionToOne
BillionToOne is hiring Director/Sr. Director of Market Access, Policy Development, Oncology, Sr. Clinical Genomics Scientist, Prenatal, Manager/Sr. Manager, Brand Marketing and more
